Drug and peptide transport in humans
From Proteopedia
(Difference between revisions)
(51 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <center><table style="background-color: #ffffd0;" width="90%"><tr><td><center> | + | <!--<center><table style="background-color: #ffffd0;" width="90%"><tr><td><center> |
<div style="font-size: 140%;"> | <div style="font-size: 140%;"> | ||
This page is under construction. This notice will be removed when it is ready. [[User:Eric Martz|Eric Martz]] 01:56, 3 December 2024 (UTC) | This page is under construction. This notice will be removed when it is ready. [[User:Eric Martz|Eric Martz]] 01:56, 3 December 2024 (UTC) | ||
</div> | </div> | ||
- | </center></td></tr></table></center> | + | </center></td></tr></table></center>--><StructureSection load='' size='350' side='right' caption='' scene='10/1066775/Chimerax-morph-pdb/2'> |
- | + | ==Peptide Transporter Function & Structure== | |
- | <StructureSection load='' size='350' side='right' caption='' scene='10/1066775/Chimerax-morph-pdb/2'> | + | Human promiscuous peptide transporter 1 ('''PepT1''') plays a crucual role in nutrition, transporting di- and tri-peptides from digested protein into intestinal cells.<ref name="kl">PMID: 34730990</ref> It is also crucial in uptake of orally delivered drugs.<ref name="kl" /> It is a member of the proton-coupled oligopeptide transporter ('''POT''') family. These secondary active transporters are powered by the [https://en.wikipedia.org/wiki/Electrochemical_gradient#Proton_gradients inward-directed electrochemical proton gradient], enabling intracellular accumulation of peptides/drugs above extracellular concentrations.<ref name="kl" />. |
- | + | {{Template:ClickGreenLinks}} | |
- | <scene name='10/1066775/ | + | <scene name='10/1066775/7pmx/3'>PepT1 is a 708-amino acid protein</scene> with an extracellular domain (beta sheets), and a transmembrane transporter domain (alpha helices) with a cytoplasmic amphipathic linker (green protrusion). The latter looks like the '''toe of a boot''' formed by the linker (toe) with the transmembrane domain. The function of the extracellular and cytoplasmic linker domains are not well understood, although the extracellular domain appears to be important in transport<ref name="cytodom">PMID: 35580608</ref>. |
- | <scene name='10/1066775/ | + | The transmembrane domain has a <scene name='10/1066775/7pmx_phobic_polar/1'>predominantly hydrophobic surface</scene> (enabling it to sit within the lipid bilayer membrane) which is <scene name='10/1066775/7pmx_phobic_polar/2'>devoid of charges</scene>. The cytoplamic linker "toe" has a net positive charge, enabling it to bind to the inner leaflet of the lipid bilayer, which typically has a negative charge. |
- | + | ==Rocker-Switch Transport Mechanism== | |
+ | PepT1 is believed to transport using a ''rocker-switch'' mechanism, in which the outer (extracellular) face opens a pocket to bind peptides to a conserved binding site, then the outer face closes and the inner (cytoplasmic) face opens to release the peptide. However, prior to 2021, no structure was captured with an outward-facing opening, despite 47 structures in the [[PDB]] for bacterial homologs, representing 10 different bacterial POTs<ref name="kl" />. | ||
- | < | + | In 2021, Killer ''et al.'' reported human PepT1 structures in outward-open conformations (with and without bound dipeptide)<ref name="kl" />. This greatly furthered understanding of the transport mechanism. In December, 2024, no additional structures with outward-open conformations have been published. |
- | <scene name='10/1066775/ | + | <scene name='10/1066775/Chimerax-morph-pdb/2'>A morph between outward-open and inward-open (partially occluded) conformations</scene> ([[7pmx]] and [[7pmy]]) of the transmembrane domain (extracellular domain hidden) illustrates the rocker-switch-like mechanism of transport. (7pmy is actually human PepT2, a different transporter with a very similar structure, and about 65% sequence identify with PepT1 in the transporter core domain.) This morph is oversimplified. Killer ''et al.'' actually captured 4 different conformations, revealing additional details of the rocker-switch mechanism. Their '''supplementary materials''' include a [https://www.science.org/doi/suppl/10.1126/sciadv.abk3259/suppl_file/sciadv.abk3259_movie_s1.zip revealing morph movie] (see also [https://www.science.org/doi/suppl/10.1126/sciadv.abk3259/suppl_file/sciadv.abk3259_sm.pdf the movie explanation]) that includes '''all 4 conformations'''. |
+ | |||
+ | <scene name='10/1066775/Chimerax-morph-pdb/3'>This view looks down into the outward-facing channel, while it closes and opens</scene>. Rotate to position the opposite side in front to see into the inward-facing open but partially occluded channel. | ||
+ | |||
+ | <center><font color="red">If morph animations fail to start, click the green link again.</font></center> | ||
+ | |||
+ | ==Channel Shapes and Sizes== | ||
+ | ===Outward Facing=== | ||
+ | The shapes and sizes of open spaces in proteins can be visualized by filling them with pseudoatoms. <scene name='10/1066775/Pacupp_7pmx_xf_s_noload/1'>Here is the shape of the outward facing channel</scene> in [[7pmx]]. The channel has been filled by [[PACUPP]] with small pseudoatoms 2.0 Å in diameter<ref name="xf">2.0 Å pseudoatoms are called "extra fine detail" in [[PACUPP]]. It defaults to "fine" (3.0 Å), and also offers "very fine" (2.4 Å) or user-specified diameters.</ref>. (3.0 Å is the van der Waals diameter of an oxygen atom). <scene name='10/1066775/Pacupp_7pmx_xf_s_noload/3'>This view shows the dipeptide inside the channel</scene>. | ||
+ | |||
+ | ===Inward Facing=== | ||
+ | <scene name='10/1066775/Pacupp_7pmy_xf_s/1'>Here is the shape of the inward facing channel</scene> in [[7pmy]] filled with 2.0 Å pseudoatoms. <scene name='10/1066775/Pacupp_7pmy_xf_s/2'>This view shows the dipeptide inside the inward-facing channel</scene>. This inward-facing opening is described as "partially occluded"<ref name="kl" />. Please recall that proteins are dynamic, and ligand movement may depend on transient openings not apparent in the static average [[cryo-EM]] structure. [http://hemoglobin.molviz.org Structures of hemoglobin] have no opening large enough to enable oxygen passage from outside to the heme iron, yet oxygen "hops on and off" very efficiently (see Section 2, View 11 in [http://hemoglobin.molviz.org this hemoglobin tutorial]). | ||
+ | |||
+ | ==Methods== | ||
+ | ===Transmembrane Domains=== | ||
+ | * The coordinates of the extracellular domain of 7pmx, sequence 381-579, were deleted from the [[PDB file]] using a [[plain text editor]]. | ||
+ | * The coordinates of the extracellular domain of 7pmy, sequence 403-606, were deleted from the [[PDB file]]. | ||
+ | These PDB files were used for making the morph, and for [[PACUPP]]. | ||
+ | ===Morph=== | ||
+ | [[Morphs]] were generated with [https://fatcat.godziklab.org/ FATCAT], with the [https://proteopedia.org/cgi-bin/morph Proteopedia PyMOL Morpher], and with [[ChimeraX]]. The dipeptide ligand was absent in the FATCAT and Proteopedia/PyMOL morphs, but was retained in the ChimeraX morph PDB file. A ChimeraX morph between the isolated transmembrane domains, with hydrogen atoms deleted, was used for the above scenes, [[Image:7pmx-y-morph-chimerax-xmemb-noh.pdb.gz]]. | ||
+ | |||
+ | Some steps in making the morph in ChimeraX are easily done from the menus, e.g. Tools, Structure Analysis, MatchMaker for superposition. Other steps must be done from commands. The complete command file for making a morph between the full-length PDB files is [https://proteopedia.org/wiki/images/a/a8/7pmx-y-morph.cxc 7pmx-y-morph.cxc]. The transmembrane domain PDB files were simply dragged and dropped into ChimeraX, instead of loading from the [[wwPDB]]. | ||
</StructureSection> | </StructureSection> | ||
+ | |||
+ | ==See Also== | ||
+ | *[https://pdb101.rcsb.org/learn/flyers-posters-and-calendars/calendar/2025-calendar-the-structural-biology-of-nutrition Structural Biology of Nutrition] at PDB-101 highlights the structures featured here (look for the brown background). | ||
+ | |||
+ | ==References and Notes== | ||
+ | <references /> |
Current revision
|
See Also
- Structural Biology of Nutrition at PDB-101 highlights the structures featured here (look for the brown background).
References and Notes
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 Killer M, Wald J, Pieprzyk J, Marlovits TC, Low C. Structural snapshots of human PepT1 and PepT2 reveal mechanistic insights into substrate and drug transport across epithelial membranes. Sci Adv. 2021 Nov 5;7(45):eabk3259. doi: 10.1126/sciadv.abk3259. Epub 2021 Nov 3. PMID:34730990 doi:http://dx.doi.org/10.1126/sciadv.abk3259
- ↑ Shen J, Hu M, Fan X, Ren Z, Portioli C, Yan X, Rong M, Zhou M. Extracellular domain of PepT1 interacts with TM1 to facilitate substrate transport. Structure. 2022 Jul 7;30(7):1035-1041.e3. PMID:35580608 doi:10.1016/j.str.2022.04.011
- ↑ 2.0 Å pseudoatoms are called "extra fine detail" in PACUPP. It defaults to "fine" (3.0 Å), and also offers "very fine" (2.4 Å) or user-specified diameters.